STAT3 and cancer: However, the transcriptional role of DNA in the DBD region may be overlooked in many studies, so the first reports of promising compounds that show the mechanism of cancer response of quinazoline ligands against DNA damage and also inhibit Stat3-induced proliferation of cancer cells demonstrate a new approach to cancer therapy [80].